Perceptive Advisors LLC

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 86
Total Value: 2694161578
Accession Number: 0001012975-25-000242
Form Type: 13F-HR
CIK: 0001224962
Manager Name: Perceptive Advisors LLC

Data Enrichment

87% identified

75 identified11 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

86 positions • $2,694,161.578K total value

86 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 3 of 5

Sort by:

Inhibrx Biosciences, Inc.

INBX|45720N103

1064026(+0.0%)

Value:

$14.9B(-9.2%)

BOSTON SCIENTIFIC CORP

BSX|101137107

130000

Value:

$13.1B

829401108

1251101

Value:

$13.1B

Inhibikase Therapeutics, Inc.

IKT|45719W205

5925000(+0.0%)

Value:

$13.0B(-32.6%)

Viking Therapeutics, Inc.

VKTX|92686J106

509005(-48.9%)

Value:

$12.3B(-69.3%)

DEXCOM INC

DXCM|252131107

178000

Value:

$12.2B

NEUROCRINE BIOSCIENCES INC

NBIX|64125C109

100050(+0.0%)

Value:

$11.1B(-19.0%)

Edgewise Therapeutics, Inc.

EWTX|28036F105

500000(-81.4%)

Value:

$11.0B(-84.7%)

Xenon Pharmaceuticals Inc.

XENE|98420N105

325324(+0.0%)

Value:

$10.9B(-14.4%)

Acrivon Therapeutics, Inc.

ACRV|004890109

5360858(+0.0%)

Value:

$10.9B(-66.3%)

Nautilus Biotechnology, Inc.

NAUT|63909J108

12594211(+0.0%)

Value:

$10.8B(-48.8%)

Aquestive Therapeutics, Inc.

AQST|03843E104

3727208

Value:

$10.8B

Contineum Therapeutics, Inc.

CTNM|21217B100

1441249(+0.0%)

Value:

$10.1B(-52.4%)

CARGO Therapeutics, Inc.

CRGX|14179K101

2431085(-34.0%)

Value:

$9.9B(-81.4%)

690145206

833333

Value:

$9.2B

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

659662(-55.6%)

Value:

$8.9B(-68.8%)

EyePoint Pharmaceuticals, Inc.

EYPT|30233G209

1537274(+0.0%)

Value:

$8.3B(-27.2%)

Adagio Medical Holdings, Inc.

ADGM|00534B100

9812419(+0.0%)

Value:

$7.9B(-23.3%)

Anteris Technologies Global Corp.

AVR|03675P102

2140000(+0.0%)

Value:

$7.8B(-34.8%)

Disc Medicine, Inc.

IRON|254604101

150000

Value:

$7.4B

Instrument	Shares		Other Manager	Value
Inhibrx Biosciences, Inc.(INBXcusip45720N103)	1.1M	QoQ 0.00% (-0) YoY NEW(+1.1M)	All Managers (Combined)	$14.9M	QoQ -9.15% (-$1.5M) YoY NEW(+$14.9M)
Boston Scientific Corp(BSXcusip101137107)	130.0K	QoQ NEW(+130.0K) YoY NEW(+130.0K)	All Managers (Combined)	$13.1M	QoQ NEW(+$13.1M) YoY NEW(+$13.1M)
(cusip829401108)✕	1.3M	QoQ NEW(+1.3M) YoY NEW(+1.3M)	All Managers (Combined)	$13.1M	QoQ NEW(+$13.1M) YoY NEW(+$13.1M)
Inhibikase Therapeutics, Inc.(IKTcusip45719W205)	5.9M	QoQ 0.00% (-0) YoY NEW(+5.9M)	All Managers (Combined)	$13.0M	QoQ -32.61% (-$6.3M) YoY NEW(+$13.0M)
Viking Therapeutics, Inc.(VKTXcusip92686J106)	509.0K	QoQ -48.88% (-486.9K) YoY -48.79% (-485.1K)	All Managers (Combined)	$12.3M	QoQ -69.32% (-$27.8M) YoY -84.92% (-$69.2M)
Dexcom Inc(DXCMcusip252131107)	178.0K	QoQ NEW(+178.0K) YoY NEW(+178.0K)	All Managers (Combined)	$12.2M	QoQ NEW(+$12.2M) YoY NEW(+$12.2M)
Neurocrine Biosciences Inc(NBIXcusip64125C109)	100.0K	QoQ 0.00% (-0) YoY -87.56% (-704.4K)	All Managers (Combined)	$11.1M	QoQ -18.97% (-$2.6M) YoY -90.02% (-$99.9M)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	500.0K	QoQ -81.38% (-2.2M) YoY -78.44% (-1.8M)	All Managers (Combined)	$11.0M	QoQ -84.65% (-$60.7M) YoY -74.00% (-$31.3M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	325.3K	QoQ 0.00% (-0) YoY -63.53% (-566.9K)	All Managers (Combined)	$10.9M	QoQ -14.41% (-$1.8M) YoY -71.58% (-$27.5M)
Acrivon Therapeutics, Inc.(ACRVcusip004890109)	5.4M	QoQ 0.00% (-0) YoY +78.22% (-2.4M)	All Managers (Combined)	$10.9M	QoQ -66.27% (-$21.4M) YoY -49.39% (-$10.6M)
Nautilus Biotechnology, Inc.(NAUTcusip63909J108)	12.6M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$10.8M	QoQ -48.75% (-$10.3M) YoY -70.71% (-$26.2M)
Aquestive Therapeutics, Inc.(AQSTcusip03843E104)	3.7M	QoQ NEW(+3.7M) YoY NEW(+3.7M)	All Managers (Combined)	$10.8M	QoQ NEW(+$10.8M) YoY NEW(+$10.8M)
Contineum Therapeutics, Inc.(CTNMcusip21217B100)	1.4M	QoQ 0.00% (-0) YoY NEW(+1.4M)	All Managers (Combined)	$10.1M	QoQ -52.35% (-$11.1M) YoY NEW(+$10.1M)
Cargo Therapeutics, Inc.(CRGXcusip14179K101)	2.4M	QoQ -33.99% (-1.3M) YoY -29.49% (-1.0M)	All Managers (Combined)	$9.9M	QoQ -81.36% (-$43.2M) YoY -87.14% (-$67.1M)
(cusip690145206)✕	833.3K	QoQ NEW(+833.3K) YoY NEW(+833.3K)	All Managers (Combined)	$9.2M	QoQ NEW(+$9.2M) YoY NEW(+$9.2M)
Viridian Therapeutics, Inc.\De(VRDNcusip92790C104)	659.7K	QoQ -55.62% (-826.8K) YoY -81.96% (-3.0M)	All Managers (Combined)	$8.9M	QoQ -68.79% (-$19.6M) YoY -86.11% (-$55.1M)
Eyepoint Pharmaceuticals, Inc.(EYPTcusip30233G209)	1.5M	QoQ 0.00% (-0) YoY +160.71% (-947.6K)	All Managers (Combined)	$8.3M	QoQ -27.24% (-$3.1M) YoY -31.63% (-$3.9M)
Adagio Medical Holdings, Inc.(ADGMcusip00534B100)	9.8M	QoQ 0.00% (-0) YoY NEW(+9.8M)	All Managers (Combined)	$7.9M	QoQ -23.33% (-$2.4M) YoY NEW(+$7.9M)
Anteris Technologies Global Corp.(AVRcusip03675P102)	2.1M	QoQ 0.00% (-0) YoY NEW(+2.1M)	All Managers (Combined)	$7.8M	QoQ -34.76% (-$4.2M) YoY NEW(+$7.8M)
Disc Medicine, Inc.(IRONcusip254604101)	150.0K	QoQ NEW(+150.0K) YoY -50.00% (-150.0K)	All Managers (Combined)	$7.4M	QoQ NEW(+$7.4M) YoY -60.13% (-$11.2M)